Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11020435 Functionalized erythroid cells

Patent 11020435 was granted and assigned to Rubius Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Rubius Therapeutics

Current Assignee

Rubius Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Xuqing Zhang0

Sivan Elloul0

Tiffany F. Chen0

Tom Wickham0

Billy Law0

Carolyn Sayre0

Jordi Mata-Fink0

Kristian Eric Teichert0

...

Date of Patent

June 1, 2021

Patent Application Number

15932341

Date Filed

February 16, 2018

Patent Citations

US Patent 10557119 Erythroid cells comprising phenylalanine ammonia lyase

US Patent 10517897 Methods related to engineered erythoid cells comprising 4-1BBL

0

US Patent 10301593 Synthetic membrane-receiver complexes

0

US Patent 10301594 Synthetic membrane-receiver complexes

0

US Patent 10329531 Synthetic membrane-receiver complexes

0

US Patent 10344263 Synthetic membrane-receiver complexes

US Patent 10456421 Compositions and methods related to engineered erythoid cells comprising 4-1BBL

0

Patent Primary Examiner

Patent abstract

Described herein are novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11020435 Functionalized erythroid cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool